Major Developments - Meizhong Jiahe (02453) has successfully constructed a self-evolving multimodal intelligent agent architecture, and the intelligent agent inspection report system has begun trial use [1] - Fuhong Hanlin (02696) received approval from the U.S. Food and Drug Administration for the clinical trial application of HLX17, a biosimilar of pembrolizumab, in patients with various resected solid tumors [1] - Xiansheng Pharmaceutical (02096) has received a clinical trial approval notice from the National Medical Products Administration for SIM0609, an antibody-drug conjugate targeting CDH17 [1] - Yuanda Pharmaceutical (00512) has received approval for a new indication in Europe for its globally innovative radioactive product SIR-Spheres® Yttrium-90 microsphere injection [1] Financial Data - Dongfeng Motor Corporation (00489) reported cumulative automobile sales of approximately 1.1386 million units in the first eight months, a year-on-year decrease of about 5.0% [1] - Dekang Agriculture and Animal Husbandry (02419) sold 813,100 pigs in August, generating sales revenue of 1.432 billion yuan [1] - Longyuan Power (00916) completed a cumulative power generation of 51.2546 million megawatt-hours in the first eight months, a year-on-year decrease of 0.001% [1] - New City Development (01030) reported a cumulative contract sales amount of approximately 13.566 billion yuan in the first eight months, a year-on-year decrease of 54.08% [1] - Qiu Tai Technology (01478) sold a total of 47.079 million camera modules in August, with a month-on-month increase of 18.4% and a year-on-year increase of 44.3% [1]
港股公告掘金 | 美中嘉和：成功构建自主进化的多模态智能体架构，智能体检报告系统开始试用